Weekly paclitaxel in patients with recurrent or metastatic head and neck cancer

被引：0
作者：
M. Tahara
H. Minami
Y. Hasegawa
K. Tomita
A. Watanabe
K. Nibu
M. Fujii
Y. Onozawa
Y. Kurono
D. Sagae
T. Seriu
M. Tsukuda
机构：
[1] National Cancer Center Hospital East,Department of Head and Neck Oncology and Plastic and Reconstructive Surgery
[2] Kobe University Hospital,Medical Oncology/Hematology, Department of Medicine
[3] Aichi Cancer Center,Department of Head and Neck Surgery
[4] National Kyushu Cancer Center,Division of Head and Neck Surgery
[5] Keiyukai Sapporo Hospital,Department of Otolaryngology
[6] Kobe University Hospital,Department of Otolaryngology
[7] Tokyo Medical Center,Head and Neck Surgery
[8] Shizuoka Cancer Center,Department of Otolaryngology, National Hospital Organization
[9] Kagoshima University Hospital,Division of Gastrointestinal Oncology and Endoscopy
[10] Bristol-Myers K.K.,Department of Otolaryngology
[11] Yokohama City University School of Medicine,Head and Neck Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Paclitaxel; Head and neck cancer; Phase II study; Weekly infusion;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：769 / 776
页数：7
相关论文
共 256 条
[11]  
Cognetti F(2001)Late phase II study of S-1 in patients with advanced head and neck cancer Gan To Kagaku Ryoho 28 1381-1390
[12]  
Cappelaere P(1998)Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil Ann Oncol 9 225-227
[13]  
de Mulder PH(1992)A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck J Clin Oncol 10 257-263
[14]  
Schornagel JH(1958)Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457-481
[15]  
Tueni EA(2010)Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial J Clin Oncol 28 8-14
[16]  
Verweij J(2003)Randomized double-blind trial of combined modality treatment with or without amifostine in unresectable stage III non-small-cell lung cancer J Clin Oncol 21 1767-1774
[17]  
Wildiers J(2004)Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine Clin Cancer Res 10 461-467
[18]  
Clerico M(1999)Estimates of the worldwide incidence of 25 major cancers in 1990 Int J Cancer 80 827-841
[19]  
Forastiere AA(2007)Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3) Cancer 110 2110-2118
[20]  
Metch B(1988)Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol Cancer Res 48 4093-4100
12345678910